Epsilon M&A Deal Report - Cytena
Transaction Multiples for the Valuation of Private Companies
Cellink / Cytena
No EMAT :
95828
Announced Date :
05/08/2019
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Cellink
Target :
Cytena
Country :
Germany
Sector of activity :
- Health Care Providers, Medical Equipment and Supplies > Health, Pharmaceuticals & Biotechnology > Medical Equipment
Business Description :
Founded in 2014 within the Institute for Microsystems Technology (IMTEK) at the University of Freiburg, Cytena is a life science company focusing on single-cell technologies. > Primarily sells...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
||||||
| Current |
|
|
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Medical Equipment » = 225
| Date | Acquirer | Target | Country | Multiples | See details |
| 11/07/2019 | Colgate-Palmolive | Laboratories Filorga Cosmetiques | Paris | ** | 95502 |
| 21/01/2019 | Private group led by Idia Capital Investissement, Amundi Private Equity Funds, Socadif and Andera Partners (ActoMezz) | Bioclinic (SELAS BIO-CLINIC) | Hauts-De-Seine | * | 94685 |
Source: Epsilon Research / EMAT
